120 related articles for article (PubMed ID: 21144834)
1. Synemin down-regulation in human hepatocellular carcinoma does not destabilize cytoskeletons in vivo.
Liu YH; Cheng CC; Lai YS; Chao WT; Pei RJ; Hsu YH; Ho CC
Biochem Biophys Res Commun; 2011 Jan; 404(1):488-93. PubMed ID: 21144834
[TBL] [Abstract][Full Text] [Related]
2. Cytokeratin 18-mediated disorganization of intermediate filaments is induced by degradation of plectin in human liver cells.
Liu YH; Ho CC; Cheng CC; Chao WT; Pei RJ; Hsu YH; Lai YS
Biochem Biophys Res Commun; 2011 Apr; 407(3):575-80. PubMed ID: 21420381
[TBL] [Abstract][Full Text] [Related]
3. Altered synemin could affect the organization of intermediate filament in human hepatocellular carcinoma.
Ho CC; Ho HC; Liu YH; Pei RJ; Cheng CC; Lee KY; Yeh KT; Lai YS
J Med; 2004; 35(1-6):171-80. PubMed ID: 18084875
[TBL] [Abstract][Full Text] [Related]
4. Effects of diode 808 nm GaAlAs low-power laser irradiation on inhibition of the proliferation of human hepatoma cells in vitro and their possible mechanism.
Liu YH; Cheng CC; Ho CC; Pei RJ; Lee KY; Yeh KT; Chan Y; Lai YS
Res Commun Mol Pathol Pharmacol; 2004; 115-116():185-201. PubMed ID: 17564317
[TBL] [Abstract][Full Text] [Related]
5. Pleomorphism of cancer cells with the expression of plectin and concept of filament bundles in human hepatocellular carcinoma.
Liu YH; Ho CC; Cheng CC; Pei RJ; Hsu YH; Yeh KT; Tsai MC; Lai YS
Res Commun Mol Pathol Pharmacol; 2007-2008; 120-121(1-6):43-54. PubMed ID: 21469503
[TBL] [Abstract][Full Text] [Related]
6. Synemin expression is widespread in liver fibrosis and is induced in proliferating and malignant biliary epithelial cells.
Schmitt-Graeff A; Jing R; Nitschke R; Desmoulière A; Skalli O
Hum Pathol; 2006 Sep; 37(9):1200-10. PubMed ID: 16938526
[TBL] [Abstract][Full Text] [Related]
7. The influence of plectin deficiency on stability of cytokeratin18 in hepatocellular carcinoma.
Cheng CC; Liu YH; Ho CC; Chao WT; Pei RJ; Hsu YH; Yeh KT; Ho LC; Tsai MC; Lai YS
J Mol Histol; 2008 Apr; 39(2):209-16. PubMed ID: 18038249
[TBL] [Abstract][Full Text] [Related]
8. Plectin deficiency on cytoskeletal disorganization and transformation of human liver cells in vitro.
Liu YH; Cheng CC; Ho CC; Chao WT; Pei RJ; Hsu YH; Ho LC; Shiu BH; Lai YS
Med Mol Morphol; 2011 Mar; 44(1):21-6. PubMed ID: 21424933
[TBL] [Abstract][Full Text] [Related]
9. Plectin 1 links intermediate filaments to costameric sarcolemma through beta-synemin, alpha-dystrobrevin and actin.
Hijikata T; Nakamura A; Isokawa K; Imamura M; Yuasa K; Ishikawa R; Kohama K; Takeda S; Yorifuji H
J Cell Sci; 2008 Jun; 121(Pt 12):2062-74. PubMed ID: 18505798
[TBL] [Abstract][Full Text] [Related]
10. The inhibitory effect of p75 neurotrophin receptor on growth of human hepatocellular carcinoma cells.
Yuanlong H; Haifeng J; Xiaoyin Z; Jialin S; Jie L; Li Y; Huahong X; Jiugang S; Yanglin P; Kaichun W; Jie D; Daiming F
Cancer Lett; 2008 Sep; 268(1):110-9. PubMed ID: 18462868
[TBL] [Abstract][Full Text] [Related]
11. Desmin mutations in the terminal consensus motif prevent synemin-desmin heteropolymer filament assembly.
Chourbagi O; Bruston F; Carinci M; Xue Z; Vicart P; Paulin D; Agbulut O
Exp Cell Res; 2011 Apr; 317(6):886-97. PubMed ID: 21262226
[TBL] [Abstract][Full Text] [Related]
12. Characterization of mammalian synemin, an intermediate filament protein present in all four classes of muscle cells and some neuroglial cells: co-localization and interaction with type III intermediate filament proteins and keratins.
Hirako Y; Yamakawa H; Tsujimura Y; Nishizawa Y; Okumura M; Usukura J; Matsumoto H; Jackson KW; Owaribe K; Ohara O
Cell Tissue Res; 2003 Aug; 313(2):195-207. PubMed ID: 12845519
[TBL] [Abstract][Full Text] [Related]
13. Intermediate filament protein synemin is present in human reactive and malignant astrocytes and associates with ruffled membranes in astrocytoma cells.
Jing R; Pizzolato G; Robson RM; Gabbiani G; Skalli O
Glia; 2005 Apr; 50(2):107-20. PubMed ID: 15657940
[TBL] [Abstract][Full Text] [Related]
14. Cell Pleomorphism and Cytoskeleton Disorganization in Human Liver Cancer.
Cheng CC; Lai YC; Lai YS; Chao WT; Tseng YH; Hsu YH; Chen YY; Liu YH
In Vivo; 2016 09-10; 30(5):549-55. PubMed ID: 27566071
[TBL] [Abstract][Full Text] [Related]
15. Differences in the distribution of synemin, paranemin, and plectin in skeletal muscles of wild-type and desmin knock-out mice.
Carlsson L; Li ZL; Paulin D; Price MG; Breckler J; Robson RM; Wiche G; Thornell LE
Histochem Cell Biol; 2000 Jul; 114(1):39-47. PubMed ID: 10959821
[TBL] [Abstract][Full Text] [Related]
16. Possible relation between histone 3 and cytokeratin 18 in human hepatocellular carcinoma.
Ho CC; Cheng CC; Liu YH; Pei RJ; Hsu YH; Yeh KT; Ho LC; Tsai MC; Lai YS
In Vivo; 2008; 22(4):457-62. PubMed ID: 18712172
[TBL] [Abstract][Full Text] [Related]
17. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
18. Synemin interacts with the LIM domain protein zyxin and is essential for cell adhesion and migration.
Sun N; Huiatt TW; Paulin D; Li Z; Robson RM
Exp Cell Res; 2010 Feb; 316(3):491-505. PubMed ID: 19853601
[TBL] [Abstract][Full Text] [Related]
19. Degradation of plectin with modulation of cytokeratin 18 in human liver cells during staurosporine-induced apoptosis.
Liu YH; Cheng CC; Ho CC; Chao WT; Pei RJ; Hsu YH; Yeh KT; Ho LC; Tsai MC; Lai YS
In Vivo; 2008; 22(5):543-8. PubMed ID: 18853744
[TBL] [Abstract][Full Text] [Related]
20. EGF receptor in human Chang liver and hepatoma HepG2 cells.
Yang EB; Wang DF; Mack P; Cheng LY
Biochem Mol Biol Int; 1996 Apr; 38(4):813-20. PubMed ID: 8728111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
